Oligon

Please note: The information displayed on this page might be outdated.
Oligon: Oligon™ is developing a new class of multimodal RNA therapeutics that can simultaneously silence numerous disease targets with a single RNA molecule to improve outcomes and combat emerging drug resistance. Our proprietary SeekR™ platform is used to digitally engineer and rapidly produce self-delivering therapeutics which target specific tissues with unprecedented precision and accuracy. We are focused on building a pipeline of products in oncology, yet our multimodal RNA platform can be harnessed to transform outcomes for any complex multigenic disease.
Sector/Industry:
Biotech Company / Healthcare/Biotechnology
Characteristics:
Based in...
US - Mountain
Clinical Stage
Pre-Clinical Stage
Disease Space
Immuno-Oncology, Oncology
Industry
Biotechnology
Investment Participation
Series A
Listing
Private
Therapeutic Modalities
Platform Technology
Website:
Address:
7201 E. Henkel Way
Suite 205
Scottsdale, AZ 85255
United States

Company Participants at Fall Private Company Showcase 2022

  • Spyro Mousses, PhD, Founder, Chief Executive Officer and Chairman of the Board

Upcoming Company Event Participation